2017
Treat to Target in Axial Spondyloarthritis: What Are the Issues?
Danve A, Deodhar A. Treat to Target in Axial Spondyloarthritis: What Are the Issues? Current Rheumatology Reports 2017, 19: 22. PMID: 28386759, DOI: 10.1007/s11926-017-0648-6.Peer-Reviewed Original ResearchConceptsT2T strategyAxial spondyloarthritisT2TPsoriatic Arthritis TrialRandomized clinical studyChronic medical conditionsLimited therapeutic optionsRoutine clinical practiceT strategyLack of evidenceAggressive managementPsoriatic arthritisRadiographic outcomesRheumatic diseasesRheumatoid arthritisClinical evidenceTherapeutic optionsArthritis trialsClinical trialsClinical studiesMedical conditionsClinical practiceTarget strategyArthritisSpondyloarthritis
2015
Screening and referral for axial spondyloarthritis—need of the hour
Danve A, Deodhar A. Screening and referral for axial spondyloarthritis—need of the hour. Clinical Rheumatology 2015, 34: 987-993. PMID: 25946983, DOI: 10.1007/s10067-015-2958-2.Peer-Reviewed Original ResearchConceptsChronic back painBack painReferral strategiesMechanical back painSelection of patientsPrimary care physiciansRehabilitation medicine physiciansManagement of axSpAEffective therapeutic agentAge of onsetPrompt diagnosisCare physiciansRheumatoid arthritisAxial spondyloarthritisAppropriate treatmentClinical studiesReferring providerEarly diagnosisMedicine physiciansGeneral populationSpondyloarthritis featuresSpine surgeonsPatientsPhysical therapistsPainIL-17 Inhibition in Axial Spondyloarthritis
Danve A, Deodhar A. IL-17 Inhibition in Axial Spondyloarthritis. Current Treatment Options In Rheumatology 2015, 1: 221-230. DOI: 10.1007/s40674-015-0020-9.Peer-Reviewed Original ResearchIL-23/ILIL-17IL-23Monoclonal antibodiesExtra-articular manifestationsTNF-α blockadeIL-17 inhibitionIL-23 receptorQuality of lifeSignificant beneficial effectDisease activityProspective trialRadiographic progressionInhibitor medicationIL-12MRI scoresPhysical functionAxial spondyloarthritisClinical studiesP40 subunitAnimal modelsBeneficial effectsWestern populationsNovel optionSpondyloarthritis